Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.9694
+0.0173 (1.82%)
At close: Oct 8, 2025, 4:00 PM EDT
0.9510
-0.0184 (-1.90%)
After-hours: Oct 8, 2025, 7:42 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $5.30 million as of October 8, 2025. Its market cap has increased by 7.97% in one year.
Market Cap
5.30M
Enterprise Value
1.79M
1-Year Change
7.97%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $5.30M, a decrease of -79.75%. That is a compound annual growth rate of -31.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 5.30M | -12.39% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
| Aug 16, 2021 | 26.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.76B |
| Johnson & Johnson | 451.68B |
| AbbVie | 404.97B |
| UnitedHealth Group | 325.59B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.56B |